Shares of Check Cap Ltd (NASDAQ:CHEK) hit a new 52-week high and low during trading on Thursday . The stock traded as low as $3.58 and last traded at $3.91, with a volume of 101114 shares traded. The stock had previously closed at $5.20.
CHEK has been the subject of several recent analyst reports. HC Wainwright raised their target price on Check Cap from $5.50 to $6.00 and gave the stock a “buy” rating in a research report on Thursday, January 11th. Zacks Investment Research raised Check Cap from a “hold” rating to a “buy” rating and set a $1.00 price objective for the company in a research report on Monday, January 15th. Finally, ValuEngine raised Check Cap from a “sell” rating to a “hold” rating in a research report on Wednesday.
Check Cap (NASDAQ:CHEK) last released its quarterly earnings data on Wednesday, April 4th. The medical research company reported ($1.22) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.15) by ($1.07). research analysts anticipate that Check Cap Ltd will post -6.48 earnings per share for the current fiscal year.
Check Cap Company Profile
Check-Cap Ltd. (Check-Cap) is a clinical-stage medical diagnostics company. The Company is engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The Company’s system consists of main components, such as ingestible scanning capsule; Capsule Positioning System (CPS), a recorder worn on the patient’s back, and a personal computer (PC)-based work station for data reconstruction and image processing.
Receive News & Ratings for Check Cap Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Check Cap and related companies with MarketBeat.com's FREE daily email newsletter.